T. J Cradick PhD

Dr. TJ Cradick, PhD has studied the design and use of the different families of nucleases enabling genome editing and gene therapy, including CRISPR/Cas nucleases. Many of these studies in academia or industry included measuring and improving specificity. TJ co-authored manuscripts detailing bioinformatics web tools: ZFN-Site, PROGNOS, SAPTA and COSMID.

Dr. TJ is the Head of Genome Editing at CRISPR Therapeutics. Prior to that he was Director of the Protein Engineering Facility at the Georgia Institute of Technology where the research included assays for CRISPR specificity and measuring off-target events. These assays helped to develop and validate new CRISPR reagents that are being applied to gene therapy targets.